Review | Rethinking clinical trial endpoints in myelodysplastic syndromes ⁩ #MyelodysplasticSyndromes
Some response criteria in MDS are silly, like the guitar amp in #ThisIsSpinalTap that goes up to 11, while others only reach 10! My editorial with ⁦⁩ in ⁦
Very nicely done by ⁦⁩ and ⁦⁩ - Rethinking clinical endpoints in #MDS